Fig. 4From: Synergism of non-thermal plasma and low concentration RSL3 triggers ferroptosis via promoting xCT lysosomal degradation through ROS/AMPK/mTOR axis in lung cancer cellsNTP + RSL3 treatment induces xCT dysfunction. A Activity of GPX4. B The protein expression of xCT and GPX4. C Level of GSH. D Effect of β-Me (100 μM) on the viability of cells treated with NTP + RSL3. E Overexpression of xCT in Calu-1 cells. F Effect of overexpression on viability of cells treated with NTP + RSL3Back to article page